You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》健倍苗苗(02161.HK)公开发售超购逾21倍 一手中签率8%
阿思达克 02-04 09:09
由雅各臣(02633.HK)分拆的从事品牌医疗保健公司健倍苗苗(02161.HK)公布招股结果,计划发售4,468.6万股股份,公开发售录超购21.47倍,每股发售价定於1.2元,一手2,000股中签率为8%。该股将於明日(2月5日)上市。中国银河国际证券(香港)为独家保荐人。

公司预计所得款项净额估计约为1,060万元,当中47.2%将用於为品牌中药的组合开发及品牌管理提供资金;43.4%将用於作为发展第三方品牌产品组合增长策略的一部分,为从第三方品牌拥有人获得更多分销权的付款提供资金;9.4%为补充营运资金及用於一般企业用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account